Implantable Pressure Sensor Global Market Report 2026

The implantable pressure sensor market size has grown rapidly in recent years. It will grow from $4.22 billion in 2025 to $4.71 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increasing demand for continuous patient monitoring, technological advances in MEMS technology, growth in minimally invasive surgeries, expanding hospital infrastructure.

The implantable pressure sensor market size is expected to see rapid growth in the next few years. It will grow to $7.37 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to growing adoption of remote patient monitoring, increasing integration with digital health platforms, rising demand for personalized treatment solutions, expanding geriatric population, increasing investment in implantable medical device R&D. Major trends in the forecast period include increasing adoption of wireless implantable pressure sensors, rising demand for continuous real time internal monitoring, growing miniaturization of implantable sensor devices, expansion of minimally invasive implantation procedures, rising clinical use in cardiovascular and neurological applications.

The increasing prevalence of cardiovascular diseases (CVDs) is projected to propel the growth of the implantable pressure sensor market in the coming years. Cardiovascular diseases include a variety of disorders affecting the heart and blood vessels, such as heart failure, coronary artery disease, hypertension, and stroke. The growing burden of CVDs is largely attributed to sedentary lifestyles, which contribute to obesity, elevated blood pressure, and an increased risk of heart-related complications. Implantable pressure sensors are essential in managing cardiovascular diseases by allowing continuous monitoring of intracardiac or arterial pressure, especially in patients with chronic conditions like heart failure. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based national public health agency, cardiovascular disease caused 919,032 deaths in the US, affecting about 1 in 3 individuals, with roughly 805,000 heart attacks, including 605,000 first-time and 200,000 repeat cases. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the implantable pressure sensor market.

Key companies operating in the implantable pressure sensor market are increasingly focusing on developing innovative implantable devices that enable continuous, real-time intraocular pressure (IOP) monitoring to improve patient outcomes in glaucoma management. Implantable devices are medical technologies designed to be placed inside the body to monitor, support, or treat physiological functions over extended periods. For example, in August 2024, Injectsense Inc., a US-based medical device company, announced the first human implantation of its ultraminiaturized intraocular pressure sensor, which has also received FDA Breakthrough Device designation. This implantable sensor is designed to provide continuous and minimally invasive pressure monitoring, allowing clinicians and patients to track glaucoma progression more accurately and adjust treatment strategies with greater precision. The device enables reliable real-time data collection while minimizing patient discomfort. Such innovations support consistent monitoring, early detection of intraocular pressure fluctuations, and improved long-term disease management, thereby contributing to better clinical outcomes for patients with glaucoma.

In November 2023, Millar Inc, a US-based manufacturer of pressure sensor technology and catheters, acquired Sentron from Siemens for an undisclosed amount. This acquisition enables Millar to expand its precision sensor design and manufacturing capabilities, reinforcing its position in medical and industrial pressure sensing, including technologies applied in implantable devices. Sentron is a Netherlands-based company providing specialized sensor technology used in implantable pressure sensor applications.

Major companies operating in the implantable pressure sensor market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., TE Connectivity Ltd, Analog Devices Inc., Keller America Inc., ICU Medical Inc., Integra LifeSciences Holdings Corporation, Raumedic AG, Endotronix Inc., Sophysa SA, Silex Microsystems AB, Millar Inc., Spiegelberg GmbH Co. KG, InjectSense Inc., Implandata Ophthalmic Products GmbH, Opsens Inc, MEMSCAP S.A., Aesculap Miethke GmbH Co. KG, First Sensor AG.

North America was the largest region in the implantable pressure sensor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable pressure sensor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the implantable pressure sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable pressure sensor market consists of sales of telemetry devices, catheter-based pressure sensors, and sensor implants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

An implantable pressure sensor is a medical device intended to be placed inside the body to continuously monitor internal pressures in organs or blood vessels. It converts physiological pressure into electrical signals that can be measured and analyzed for clinical or research purposes. These sensors provide real-time data and accurate measurements to support medical evaluations and treatment planning.

The key products of implantable pressure sensors include wireless implantable pressure sensors and wired implantable pressure sensors. Wireless sensors monitor internal body pressure in real-time, improving patient management and clinical outcomes. Technologies include microelectromechanical systems (MEMS), fiber optic, and others. Applications include cardiovascular, neurology, urology, intraocular, and other fields, serving hospitals, ambulatory surgical centers, specialty clinics, and other end-users.

Tariffs on imported semiconductor components, MEMS devices, and medical-grade materials are impacting the implantable pressure sensor market by increasing manufacturing costs, particularly affecting wireless implantable pressure sensors and advanced MEMS-based technologies. Regions reliant on cross-border medical device supply chains such as North America, Europe, and Asia-Pacific are most affected, especially in cardiovascular and neurology applications. Higher import duties may slow procurement for hospitals and specialty clinics; however, tariffs are also encouraging domestic production of medical electronics, strengthening local supply chains and promoting regional innovation in implantable sensor manufacturing.

The implantable pressure sensor market research report is one of a series of new reports that provides implantable pressure sensor market statistics, including implantable pressure sensor industry global market size, regional shares, competitors with a implantable pressure sensor market share, detailed implantable pressure sensor market segments, market trends and opportunities, and any further data you may need to thrive in the implantable pressure sensor industry. This implantable pressure sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.